Reduced Turnover and Accelerated Growth for a Small Molecule CDMO

The Challenge
A small molecule CDMO faced over a 70% turnover rate, struggled to meet production timelines, retain clients, and hit revenue goals.

Our Approach
Partnering with the client under a new CEO, Barrington James was able to identify the root causes of the challenges, assess the company’s history, and develop a tailored plan of action. Barrington James acted as a brand ambassador for the client’s rebranding efforts and hiring strategies, positioning them effectively in the market.

We prioritized transparency throughout the process, influencing strategic hiring decisions, and held bi-weekly alignment meetings with leadership to ensure progress was on track. As the client expanded globally with new private equity investment, Barrington James adapted its services to support their UK operations and rebranding efforts.

Results

• Barrington James and the team successfully reduced turnover from over 70% to less than 11% by making 13 key hires in 18 months, including leadership roles across sales, quality, operations, R&D, and marketing.
• Achieved a 100% contract completion rate for contractors.
• Reduced turnover from 70% to 11%.
• Supported global expansion with strategic senior hires.
• Enhanced employee satisfaction and fostered leadership development across the organization.

Client Quote:
“Since partnering with Barrington James, we’ve been able to decrease turnover from over 70% to less than 11%, boost employee happiness and satisfaction ratings, and build out strong leadership teams along with a robust support staff. It has been a great partnership, and we look forward to continuing our work together this year.” – Chief Executive Officer